值得注意的是，这个男孩不但在琼脂凝胶扩散试验中显示含有澳大利亚抗原，而且还患有肝炎。
Significantly, this boy not only displayed Aa by the agar gel diffusion test but he also had hepatitis.
乙型肝炎表面抗原-这直接测试是否存在病毒。
Hepatitis B surface Antigen - this tests directly for the presence of virus.
目的提高乙型肝炎病毒表面抗原在人参愈伤组织细胞中的表达。
Objective To increase the expression level of HBsAg in ginseng callus cells.
早期的研究已经显示，对慢性乙型肝炎e抗原阴性的患者进行48周阿德福韦治疗后，获得了临床上的改善。
Early research has shown that a 48-week course of adefovir provides clinical improvements in patients with HBeAg-negative chronic hepatitis B.
观察慢性丙型肝炎（CHC）患者肝组织及外周血单核细胞（PBMC）FAS抗原表达对CHC病情的影响，进而探讨FAS系统与CHC 的关系及临床意义。
To study the expression of FAS antigens in peripheral blood mononuclear cells(PBMC) and liver tissues of patients with chronic hepatitis C (CHC) and the relationship between them.
方法：采用免疫组化法检测9例丙型肝炎患者肾、心、胰和肠等肝外组织内hcv抗原，并与肝组织内抗原表达进行对比研究。
Methods: Immunohistochemical assay was used to determine the expression of HCV antigen in the kidneys, heart, pancreas, intestine and liver in 9 patients with viral hepatitis c.
比较了部分国产抗-丙型肝炎病毒(HCV)检测试剂盒与新加坡试剂盒的灵敏度、阳性检出率和特异性，讨论了试剂盒的抗原成分和诊断价值。
The sensitivity, positive testing rate and specificity of some domestic made anti-HCV testing kits were compared. Also, the antigen components and diagnostic value of the kits were discussed.
目的探讨丙型肝炎病毒（HCV）核心抗原酶联免疫诊断试剂检测早期HCV感染“窗口期”样本的可行性。
Objective To evaluate the performances of HCV core antigen(HCV-cAg)testing in comparison to HCV RNA and Anti-HCV detection during the preseroconversion period.
目的研究丙型肝炎病毒(HCV)抗原在患者肝组织中的分布状况及其相互关系。
Objective To investigate distributions and correlation of HCV antigens in the liver tissues.
乙型肝炎表面抗原a，山羊抗，多克隆。
本发明的组合物可以包含乙型肝炎病毒抗原和其他共同给药抗原的组合。
The inventive compositions can comprise a combination of the hepatitis B antigen and other coadministered antigens.
目的建立室内质控参考品以鉴别诊断试剂的质量和控制操作误差，提高乙型肝炎病毒表面抗原的检测准确度。
Objective to establish internal quality control to distinguish the quality of diagnostic Kit and control operate error and improve the accuracy of HBsAg detection.
目的为了研究我国丙型肝炎病毒(HCV)诊断试剂用抗原的质量，加快改进丙型肝炎病毒抗体诊断试剂。
Using anti-HCV antibody screening assay to control the quality for blood is the main measure for preventing transmission of HCV in China.
可溶性HLA - I类抗原含量的变化反映了慢性乙型肝炎治疗中患者免疫功能受到调节。
Soluble HLA-I antigen levels may reflect the modulation of the patients immune function through CHB treatment.
结论HBV感染PBL可能是慢性乙型肝炎患者外周血淋巴细胞HLA I类抗原表达降低的重要影响因素之一。
Conclusion HBV infected PBL may be one of important factors responsible for affecting the HLA class I antigen expression on PBL in the patients with CHB.
目的：研究乙型肝炎表面抗原携带者及其子女间的遗传传递。
Objective: to study genetic transmission from the parents with HBsAg to their children.
目的提高CHO细胞表达的重组乙型肝炎病毒表面抗原的免疫原性。
Objective To improve the immunogenicity of recombinant HBsAg expressed in CHO cells.
此病人除有免淋的全部形态学三联症及异常蛋白血症外，还伴有乙型肝炎表面抗原血症及冷凝集素血症。
The patient not only had all the morphologic triad of IBLD with dysproteinemia but also associated with HBsAg and cold agglutinin existing in his blood.
利用生物素-亲和素生物放大系统的原理，建立了新的检测细胞培养的甲型肝炎病毒抗原的方法。
A new technique used to detect HAAg in human diploid embryonic lung fibroblast ( HDLF ) cell culture was developed.
目的应用多抗原肽（MAP）研究丙型肝炎病毒包膜糖蛋白高变区1（HVR1）的抗原性。
Objective To study the immunogenicity of multiple antigen peptide (MAP) corresponding to the hypervariable region 1(HVR1) within the putative envelope glycoprotein E2/NS1 of hepatitis C virus(HCV).
这表明表面抗原在乙肝病毒感染过程中具有特殊的作用，在乙型肝炎发病机制中扮演了重要的角色。
This unique phenomenon indicates that HBsAg plays an important role in HBV infection and pathogenesis of the disease.
对重组乙型肝炎（乙肝） 病毒前S1抗原（1- 42 ）及核心抗原（1- 144 ）表达的融合蛋白CS1进行了免疫原性的研究分析，以便为探索HBV治疗性疫苗的研制提供实验依据。
The aim of this study was to express a fusion protein of HBV preS1 Ag(1-42) and HBcAg(1-144) and analyze its immunogenicity for further study of HBV therapeutic vaccine.
对重组乙型肝炎（乙肝） 病毒前S1抗原（1- 42 ）及核心抗原（1- 144 ）表达的融合蛋白CS1进行了免疫原性的研究分析，以便为探索HBV治疗性疫苗的研制提供实验依据。
The aim of this study was to express a fusion protein of HBV preS1 Ag(1-42) and HBcAg(1-144) and analyze its immunogenicity for further study of HBV therapeutic vaccine.
应用推荐